A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville,...
Response
A new blood test developed by the Institute of Cancer Research predicts how well patients with advanced breast cancer will...
Identification of a nine-gene immune signature that predicts efficacy of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) treatment in first-line patients. Credit:...
"Progress made in reducing heart attack deaths provides a roadmap to address rising mortality rates from arrythmias, heart failure and...
Results from a phase 1 trial show an anti-cancer response in patients with RCC from a personalized cancer vaccine.A phase...
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have uncovered new details about the role of a protein called interferon regulatory factor...
